Good morning traders! This is the official account to find out all the breaking news that may/may not affect your trading decision such as economic policies, political moves, global agendas, and more. BUT first, to start off your day with a bang, here's a recap of the important news we think you sho

到目前为止，这两种新冠疫苗因潜在的副作用而被停止使用。 考虑到疫苗的研发速度，这确实让人怀疑其他疫苗是否会面临类似的问题。有许多媒体报道了可怕的副作用。 因此，在EMA正式审查之前，当局停止了阿斯利康/牛津疫苗的推广。随后，EMA以没有证据表明两者之间存在联系为由，批准了该疫苗。 但后来，他们改变了意见，认为事实上，血栓和疫苗之间存在联系。 那么，这到底是怎么回事呢？ 深入探讨疫苗的技术问题可能需要一整本书，但我们需要解决可能影响市场的主要问题。 第一个问题是强生疫苗甚至阿斯利康疫苗回归到全面接种的可能性有多大。有的国家是限制在某些年龄段，有的国家则没有。 我们把这个问题梳理一下。 在审查时的

Good morning traders! This is the official account to find out all the breaking news that may/may not affect your trading decision such as economy policies, political moves, global agendas and more. BUT first, to start off your day with a bang, here's a recap of the important news we think you shoul

Good morning traders! This is the official account to find out all the breaking news that may/may not affect your trading decision such as economy policies, political moves, global agendas and more. BUT first, to start off your day with a bang, here's a recap of the important news we think you shoul

“We continue to believe in a positive benefit-risk profile of COVID-19 vaccine,” Johnson & Johnson said in response to the statement released after the US CDC Advisory Committee meeting. more to come ....

Having stopped the usage of Johnson & Johnson’s (J&J) coronavirus (COVID-19) vaccine in all 50 US states the previous day, US Centers for Disease Control and Prevention (CDC) extends the pause on the usage of the vaccine amid a lack of more data to assess the risk. The CDC panel concludes wi

Having heard from the US Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC), Johnson & Johnson came out with the official announcement, during early Wednesday in Asia, suggesting a delay in vaccine rollout in Europe. The drugmaker also said that it is aware o

(Reuters) -U.S. federal health agencies on Tuesday recommended pausing the use of Johnson & Johnson’s single-dose COVID-19 vaccine after six recipients developed a rare disorder involving blood clots. The U.S. Centers for Disease Control and Prevention will hold an advisory meeting on Wednesday

Drug maker Johnson & Johnson (JNJ) announced its agreement to provide up to 400 million doses of its single-shot Covid-19 vaccine candidate to African Union's 55 member states. Further, Johnson & Johnson, as announced earlier, expects to enter into an Advance Purchase Agreement or APA with G

Johnson & Johnson (JNJ) said Thursday that the European Commission has granted a Conditional Marketing Authorization for its single-dose COVID-19 vaccine. The authorization comes hours after receiving a positive opinion from the European Medicines Agency's the Committee for Medicinal Products fo

Johnson & Johnson (JNJ) said that its single-dose COVID-19 vaccine candidate has received a positive opinion from the Committee for Medicinal Products for Human Use or CHMP of the European Medicines Agency or EMA. The CHMP has recommended Conditional Marketing Authorization for the vaccine candi

President Joe Biden announced the U.S. Government's plan to buy additional 100 million doses of Johnson & Johnson's single-shot COVID-19 vaccine. The US Department of Health and Human Services would make the purchase to ensure maximum flexibility during the pandemic time. The timing of the suppl

NASDAQ 100 (as of Mar 8, 2021 at 12.30 p.m.) Source: Yahoo Finance SPX 500 (as of Mar 8, 2021 at 12.30 p.m.) Source: Yahoo Finance US30 (as of Mar 8, 2021 at 12.30 p.m.) Source: Yahoo Finance At the beginning of the brand-new week, the US30 futures rose 0.5% and the SPX500 futures increased 0.4%. Ho

The Johnson & Johnson one-shot vaccine has been approved by the US FDA this weekend which now makes it the third approved vaccine for the US, risk-on news for the open this week when vaccinations will begin. And for the first time since early November, fewer than 50,000 patients are hospitalized